Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipo4Me Vit. D3
- Development stage
- Preclinical
- Lead developer
- AronPharma
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Oral
01
Overview
Lipo4Me Vit. D3 is a liposomal nutraceutical formulation of vitamin D3 (cholecalciferol) developed by AronPharma. It is designed as a food supplement to address vitamin D deficiency. The liposomal delivery system is intended to enhance the bioavailability and absorption of the vitamin compared to traditional oral forms by protecting the active ingredient from degradation in the digestive tract and facilitating its uptake through lipid membranes. It is currently part of AronPharma's research and development pipeline focusing on improved delivery systems for essential nutrients.
- Brand names
- Lipo4Me Vit. D3Lipo-4Me Vit. D3Lipo 4Me Vit. D3
- Other names
- liposomal vitamin D3Lipo4Me Vitamin D3Lipo-4Me Vitamin D3Lipo 4Me Vitamin D3
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Lipo4Me Vit. D3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipo4Me Vit. D3.